Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Charming Medical Limited Class A Ordinary Shares, Common Stock

MCTA

NAQ

$29.45

+$1.95

(7.09%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$465.80M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

715.60K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$4.3 L

$31.24 H

$29.45

About Charming Medical Limited Class A Ordinary Shares, Common Stock

Charming Medical Limited, through its subsidiaries, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. Its services includes womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine (TCM)-inspired prenatal massage, and Indonesian traditional abdominal binding. The company also provides TCM-inspired supplements products, which includes Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets; and beauty products, including ginseng soothing anti-allergy moisturizing wash for skin issues, and scalp health. In addition, it offers consultancy services to provide TCM-inspired therapy technical training and dietary therapy training to other well-established and reputable beauty salons, massage centers, and similar institutions. Further, the company's products are used for the treatment of alleviating premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal care, breast health, uterine health, enhance physical weakness, balance endocrine functions, and other common women's health issues. it operates wellness centres. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong. more

Returns

Data is not properly formatted.

Time Frame	MCTA		S&P500
1-Week Return	22.28%%	%	-0.29%%
1-Month Return	292.86%%	%	4.32%%

Financials

	Mar '23	Mar '24	Mar '25
Total Revenue	3.53M	6.02M	6.22M	[{"date":"2023-03-31","value":56.75,"profit":true},{"date":"2024-03-31","value":96.68,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Cost of Revenue	2.04M	2.10M	2.04M	[{"date":"2023-03-31","value":96.93,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":97.14,"profit":true}]
Gross Profit	1.49M	3.91M	4.18M	[{"date":"2023-03-31","value":35.74,"profit":true},{"date":"2024-03-31","value":93.63,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Margin	42.31%	65.07%	67.19%	[{"date":"2023-03-31","value":62.97,"profit":true},{"date":"2024-03-31","value":96.84,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Operating Expenses	2.02M	2.91M	2.79M	[{"date":"2023-03-31","value":69.37,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":96.09,"profit":true}]
Operating Income	(521.34K)	1.01M	1.39M	[{"date":"2023-03-31","value":-37.53,"profit":false},{"date":"2024-03-31","value":72.63,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	(51.41K)	(175.60K)	(121.20K)	[{"date":"2023-03-31","value":-5141400,"profit":false},{"date":"2024-03-31","value":-17560200,"profit":false},{"date":"2025-03-31","value":-12119700,"profit":false}]
Pre-Tax Income	(420.47K)	1.00M	1.44M	[{"date":"2023-03-31","value":-29.3,"profit":false},{"date":"2024-03-31","value":69.92,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income Taxes	(84.86K)	181.75K	236.08K	[{"date":"2023-03-31","value":-35.95,"profit":false},{"date":"2024-03-31","value":76.99,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income After Taxes	(335.61K)	821.74K	1.20M	[{"date":"2023-03-31","value":-27.99,"profit":false},{"date":"2024-03-31","value":68.53,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Income From Continuous Operations	(335.61K)	821.74K	1.20M	[{"date":"2023-03-31","value":-27.99,"profit":false},{"date":"2024-03-31","value":68.53,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	(305.12K)	777.81K	1.20M	[{"date":"2023-03-31","value":-25.45,"profit":false},{"date":"2024-03-31","value":64.87,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

EPS (Diluted)	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

	Mar '23	Mar '24	Mar '25
Total Revenue	-	70.37%	3.43%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":4.88,"profit":true}]
Cost of Revenue	-	3.16%	(2.86%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-90.28,"profit":false}]
Gross Profit	-	162.00%	6.81%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":4.2,"profit":true}]
Gross Margin	-	53.79%	3.26%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":6.07,"profit":true}]

Operating Expenses	-	44.16%	(3.91%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-8.86,"profit":false}]
Operating Income	-	(293.51%)	37.68%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-779.05,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	241.55%	(30.98%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-12.83,"profit":false}]
Pre-Tax Income	-	(338.66%)	43.02%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-787.27,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Income Taxes	-	(314.17%)	29.89%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-1050.98,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Income After Taxes	-	(344.85%)	45.92%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-750.99,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Income From Continuous Operations	-	(344.85%)	45.92%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-750.99,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income	-	(354.92%)	54.16%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-655.3,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

EPS (Diluted)	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Mar '23	Mar '24	Mar '25
Total Assets
Current Assets	4.12M	3.67M	3.37M	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":89.02,"profit":true},{"date":"2025-03-31","value":81.73,"profit":true}]
Non-current Assets	2.26M	1.21M	1.99M	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":53.63,"profit":true},{"date":"2025-03-31","value":87.82,"profit":true}]
Total Assets	6.38M	4.88M	5.36M	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":76.47,"profit":true},{"date":"2025-03-31","value":83.89,"profit":true}]

Total Liabilities
Current Liabilities	7.17M	5.88M	4.95M	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":82.02,"profit":true},{"date":"2025-03-31","value":69.03,"profit":true}]
Non-current Liabilities	484.26K	148.25K	358.03K	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":30.61,"profit":true},{"date":"2025-03-31","value":73.93,"profit":true}]
Total Liabilities	7.65M	6.03M	5.31M	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":78.77,"profit":true},{"date":"2025-03-31","value":69.34,"profit":true}]

Total Shareholders' equity
Common Stock	1.53K	1.53K	1.53K	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Retained Earnings	(1.16M)	(1.08M)	119.44K	[{"date":"2023-03-31","value":-973.31,"profit":false},{"date":"2024-03-31","value":-903.91,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Other Stockholders' Equity	(1.53K)	(1.53K)	(68.16K)	[{"date":"2023-03-31","value":-153400,"profit":false},{"date":"2024-03-31","value":-153400,"profit":false},{"date":"2025-03-31","value":-6816300,"profit":false}]
Total Shareholders' equity	(1.16M)	(1.08M)	49.24K	[{"date":"2023-03-31","value":-2352.84,"profit":false},{"date":"2024-03-31","value":-2192.07,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	6.49M	4.95M	5.36M	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":76.2,"profit":true},{"date":"2025-03-31","value":82.47,"profit":true}]

	Mar '23	Mar '24	Mar '25
Total Assets
Current Assets	-	(10.98%)	(8.19%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]
Non-current Assets	-	(46.37%)	63.74%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-72.74,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Total Assets	-	(23.53%)	9.71%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-242.43,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	(17.98%)	(15.84%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]
Non-current Liabilities	-	(69.39%)	141.51%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-49.03,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Total Liabilities	-	(21.23%)	(11.97%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Retained Earnings	-	(7.13%)	(111.06%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]
Other Stockholders' Equity	-	-	4343.48%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Total Shareholders' equity	-	(6.83%)	(104.56%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	(23.80%)	8.23%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-289.25,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

	Mar '24	Sep '24	Mar '25
Total Assets
Current Assets	3.67M	3.31M	3.37M	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-09-30","value":90.37,"profit":true},{"date":"2025-03-31","value":91.81,"profit":true}]
Non-current Assets	1.21M	2.06M	1.99M	[{"date":"2024-03-31","value":58.94,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":96.51,"profit":true}]
Total Assets	4.88M	5.37M	5.36M	[{"date":"2024-03-31","value":90.83,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":99.65,"profit":true}]

Total Liabilities
Current Liabilities	5.88M	5.60M	4.95M	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-09-30","value":95.18,"profit":true},{"date":"2025-03-31","value":84.16,"profit":true}]
Non-current Liabilities	148.25K	459.59K	358.03K	[{"date":"2024-03-31","value":32.26,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":77.9,"profit":true}]
Total Liabilities	6.03M	6.06M	5.31M	[{"date":"2024-03-31","value":99.54,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":87.63,"profit":true}]

Total Shareholders' equity
Common Stock	1.53K	1.53K	1.53K	[{"date":"2024-03-31","value":100,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Retained Earnings	(1.08M)	(610.83K)	119.44K	[{"date":"2024-03-31","value":-903.91,"profit":false},{"date":"2024-09-30","value":-511.4,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Other Stockholders' Equity	(1.53K)	(68.16K)	(68.16K)	[{"date":"2024-03-31","value":-153400,"profit":false},{"date":"2024-09-30","value":-6816300,"profit":false},{"date":"2025-03-31","value":-6816300,"profit":false}]
Total Shareholders' equity	(1.08M)	(681.05K)	49.24K	[{"date":"2024-03-31","value":-2192.07,"profit":false},{"date":"2024-09-30","value":-1383.05,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	4.95M	5.37M	5.36M	[{"date":"2024-03-31","value":92.07,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":99.65,"profit":true}]

	Mar '24	Sep '24	Mar '25
Total Assets
Current Assets	-	(9.63%)	1.60%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":-601.48,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]
Non-current Assets	-	69.67%	(3.49%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-5.01,"profit":false}]
Total Assets	-	10.09%	(0.35%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-3.48,"profit":false}]

Total Liabilities
Current Liabilities	-	(4.82%)	(11.57%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]
Non-current Liabilities	-	210.01%	(22.10%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-10.52,"profit":false}]
Total Liabilities	-	0.46%	(12.37%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-2687.13,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Retained Earnings	-	(43.42%)	(119.55%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]
Other Stockholders' Equity	-	4343.48%	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Total Shareholders' equity	-	(36.91%)	(107.23%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	8.61%	(0.35%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-03-31","value":-4.08,"profit":false}]

	Mar '23	Mar '24	Mar '25
Operating Activities
Net Operating Cash Flow	2.43M	295.43K	425.89K	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":12.14,"profit":true},{"date":"2025-03-31","value":17.5,"profit":true}]

Investing Activities
Net Investing Cash Flow	(606.19K)	(210.60K)	(2.23M)	[{"date":"2023-03-31","value":-60619400,"profit":false},{"date":"2024-03-31","value":-21059800,"profit":false},{"date":"2025-03-31","value":-222945800,"profit":false}]

Financing Activities
Net Financing Cash Flow	(1.43M)	100.14K	521.30K	[{"date":"2023-03-31","value":-274.37,"profit":false},{"date":"2024-03-31","value":19.21,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Net Change in Cash	402.99K	174.46K	(1.29M)	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":43.29,"profit":true},{"date":"2025-03-31","value":-319.34,"profit":false}]

Free Cash Flow
Free Cash Flow	1.83M	84.83K	138.36K	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":4.64,"profit":true},{"date":"2025-03-31","value":7.57,"profit":true}]

	Mar '23	Mar '24	Mar '25
Operating Activities
Net Operating Cash Flow	-	(87.86%)	44.16%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-198.97,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(65.26%)	958.63%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-6.81,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(107.00%)	420.55%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-25.44,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Net Change in Cash	-	(56.71%)	(837.63%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(95.36%)	63.10%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-151.12,"profit":false},{"date":"2025-03-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	MCTA
Cash Ratio	0.56
Current Ratio	0.68
Quick Ratio	0.68

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	MCTA
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	MCTA
Debt Ratio Lower is generally better. Negative is bad.	0.99
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.01

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	MCTA
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Charming Medical Limited Class A Ordinary Shares share price today?

Charming Medical Limited Class A Ordinary Shares (MCTA) share price today is $29.45

Can Indians buy Charming Medical Limited Class A Ordinary Shares shares?

Yes, Indians can buy shares of Charming Medical Limited Class A Ordinary Shares (MCTA) on Vested. To buy Charming Medical Limited Class A Ordinary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MCTA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Charming Medical Limited Class A Ordinary Shares be purchased?

Yes, you can purchase fractional shares of Charming Medical Limited Class A Ordinary Shares (MCTA) via the Vested app. You can start investing in Charming Medical Limited Class A Ordinary Shares (MCTA) with a minimum investment of $1.

How to invest in Charming Medical Limited Class A Ordinary Shares shares from India?

You can invest in shares of Charming Medical Limited Class A Ordinary Shares (MCTA) via Vested in three simple steps:

Click on Sign Up or Invest in MCTA stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Charming Medical Limited Class A Ordinary Shares shares

What is Charming Medical Limited Class A Ordinary Shares 52-week high and low stock price?

The 52-week high price of Charming Medical Limited Class A Ordinary Shares (MCTA) is $31.24. The 52-week low price of Charming Medical Limited Class A Ordinary Shares (MCTA) is $4.3.

What is Charming Medical Limited Class A Ordinary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Charming Medical Limited Class A Ordinary Shares (MCTA) is 0.00

What is the Market Cap of Charming Medical Limited Class A Ordinary Shares?

The market capitalization of Charming Medical Limited Class A Ordinary Shares (MCTA) is $465.80M

What is Charming Medical Limited Class A Ordinary Shares’s stock symbol?

The stock symbol (or ticker) of Charming Medical Limited Class A Ordinary Shares is MCTA

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Charming Medical Limited Class A Ordinary Shares, Common Stock

MCTA

NAQ

$29.45

+$1.95

(7.09%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Charming Medical Limited Class A Ordinary Shares, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²